{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:28:35Z","timestamp":1791221315492,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":2140,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3945\/ajcn.116.143131","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T01:50:18Z","timestamp":1486000218000},"page":"882-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT)"],"prefix":"10.1016","volume":"105","author":[{"given":"Xianhui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genfu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.116.143131_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.3945\/ajcn.116.143131_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.3945\/ajcn.116.143131_bib3","doi-asserted-by":"crossref","first-page":"e56864","DOI":"10.1371\/journal.pone.0056864","article-title":"High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2013","journal-title":"PLoS One"},{"key":"10.3945\/ajcn.116.143131_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ndt\/gft378","article-title":"Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis","volume":"29","author":"Bose","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.3945\/ajcn.116.143131_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.11.051","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies","volume":"232","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.3945\/ajcn.116.143131_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J Cardiol"},{"key":"10.3945\/ajcn.116.143131_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.3945\/ajcn.116.143131_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/CEJ.0000000000000161","article-title":"Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study","volume":"25","author":"Chen","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"10.3945\/ajcn.116.143131_bib9","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3899\/jrheum.110092","article-title":"Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions","volume":"38","author":"Chohan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.3945\/ajcn.116.143131_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.28403","article-title":"Drug-Induced Liver Injury Network (DILIN): febuxostat-induced acute liver injury","volume":"63","author":"Bohm","year":"2016","journal-title":"Hepatology"},{"key":"10.3945\/ajcn.116.143131_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.3945\/ajcn.116.143131_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0021-9258(17)43612-X","article-title":"Inhibition of mammalian xanthine oxidase by folate compounds and amethopterin","volume":"259","author":"Lewis","year":"1984","journal-title":"J Biol Chem"},{"key":"10.3945\/ajcn.116.143131_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/JIM.0000000000000152","article-title":"Assessment of a possible link between hyperhomocysteinemia and hyperuricemia","volume":"63","author":"Cohen","year":"2015","journal-title":"J Investig Med"},{"key":"10.3945\/ajcn.116.143131_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/annrheumdis-2012-202023","article-title":"Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout","volume":"72","author":"Slot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.3945\/ajcn.116.143131_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/78.4.690","article-title":"A case-control study of the association of diet and obesity with gout in Taiwan","volume":"78","author":"Lyu","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.143131_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2169\/internalmedicine.54.2931","article-title":"Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized, double-blind, parallel-controlled clinical trial","volume":"54","author":"Li","year":"2015","journal-title":"Intern Med"},{"key":"10.3945\/ajcn.116.143131_bib17","first-page":"57","article-title":"[Effect of low doses of folic acid on selected biochemical atherosclerosis risk factors\u2013preliminary study.]","volume":"19","author":"Mierzecki","year":"2005","journal-title":"Pol Merkuriusz Lekarski"},{"key":"10.3945\/ajcn.116.143131_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"key":"10.3945\/ajcn.116.143131_bib19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","article-title":"Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal sub-study of the China Stroke Primary Prevention Trial (CSPPT)","volume":"176","author":"Xu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.3945\/ajcn.116.143131_bib20","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.116.143131_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8 Suppl","key":"10.3945\/ajcn.116.143131_bib22","doi-asserted-by":"crossref","first-page":"2361S","DOI":"10.1093\/jn\/132.8.2361S","article-title":"Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology","volume":"132","author":"James","year":"2002","journal-title":"J Nutr"},{"key":"10.3945\/ajcn.116.143131_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2007.01.007","article-title":"Synergistic effects of S-adenosylhomocysteine and homocysteine on DNA damage in a murine microglial cell line","volume":"379","author":"Lin","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.3945\/ajcn.116.143131_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tox.2011.10.016","article-title":"S-Adenosylhomocysteine enhances DNA damage through increased \u03b2-amyloid formation and inhibition of the DNA-repair enzyme OGG1b in microglial BV-2 cells","volume":"290","author":"Lin","year":"2011","journal-title":"Toxicology"},{"key":"10.3945\/ajcn.116.143131_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.nutres.2015.10.003","article-title":"Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke","volume":"36","author":"Spence","year":"2016","journal-title":"Nutr Res"},{"key":"10.3945\/ajcn.116.143131_bib26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.107.160184","article-title":"Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA\/KORA cohort study","volume":"28","author":"Meisinger","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/ajcn.116.143131_bib27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"H\u00f8ieggen","year":"2004","journal-title":"Kidney Int"},{"key":"10.3945\/ajcn.116.143131_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/hct083","article-title":"Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality","volume":"106","author":"Stack","year":"2013","journal-title":"QJM"},{"key":"10.3945\/ajcn.116.143131_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"10.3945\/ajcn.116.143131_bib30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/HJH.0b013e32835200f9","article-title":"An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials","volume":"30","author":"Smink","year":"2012","journal-title":"J Hypertens"},{"key":"10.3945\/ajcn.116.143131_bib31","doi-asserted-by":"crossref","first-page":"762820","DOI":"10.1155\/2015\/762820","article-title":"Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.3945\/ajcn.116.143131_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/nu7010074","article-title":"Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis","volume":"7","author":"Yang","year":"2014","journal-title":"Nutrients"},{"key":"10.3945\/ajcn.116.143131_bib33","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/STROKEAHA.115.009111","article-title":"Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients: a population-based, prospective cohort study","volume":"46","author":"Han","year":"2015","journal-title":"Stroke"},{"key":"10.3945\/ajcn.116.143131_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcn\/86.3.718","article-title":"Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004","volume":"86","author":"Pfeiffer","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.143131_bib35","doi-asserted-by":"crossref","first-page":"M660","DOI":"10.1093\/gerona\/57.10.M660","article-title":"Effect of aging on serum uric acid levels: longitudinal changes in a large Japanese population group","volume":"57","author":"Kuzuya","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3945\/ajcn.116.143131_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.3945\/ajcn.116.143131_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522048341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522048341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3945\/ajcn.116.143131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T12:28:27Z","timestamp":1685449707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916522048341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0002916522048341"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.116.143131","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.116.143131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}